News

emlidy has a boxed warning in its product label regarding the risks of lactic acidosis/severe hepatomegaly with steatosis and post-treatment severe acute exacerbation of hepatitis B. See below

Drug resistance contributes to nearly 600,000 cancer deaths in the US per year. The partners will use Watson's computational and machine learning methods to study drug resistance in

The primary endpoints of the ARISE-2 trial are the change in ocular discomfort and the change in inferior corneal staining at baseline (prior to first dose) and at

The Patent Cooperation Treaty (PCT) is an international patent law treaty, which provides a unified procedure for filing patent applications to protect inventions in each of its member

Sorrento acquired approximately 72% of the outstanding common stock of SCILEX for a net purchase price of up to approximately $47.6m, payable in a combination of cash and

The partial hold was placed on the study in August of this year, requesting chemistry, manufacturing, and controls data and clarifications to several trial design questions. Now that

The companies formed a clinical trial collaboration to evaluate the combination treatment. The dose-escalation part assessing IPI-549 as a monotherapy in Infinity’s phase 1 trial is continuing, and

Data from the company's Phase 3 sickle cell disease trial demonstrated a reduction in the frequency of sickle cell crises and hospitalizations, as well as a reduction in

The agreement was facilitated by the Johnson & Johnson Innovation Centre in London. BenevolentAI has acquired a license to a select number of novel clinical stage drug candidates